BioSpace News Archive

The global animal blood plasma products and derivatives market is has a fragmented vendor landscape due to the presence of several players, Transparency Market Research observes.

ERYTECH Pharma announced the acceptance of an abstract with the results of its expanded access program evaluating eryaspase in acute lymphoblastic leukemia for poster presentation at the upcoming 2021 American Society of Hematology Annual Meeting, which will be held from December 11-14, 2021, both inAtlanta, Georgiaand virtually.

Biophytis SA, a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging, including severe respiratory failure in patients suffering from COVID-19,announces that patient recruitment in the United States, paused in May while waiting for results of the Interim Analysis 2, has restarted.

BioArctic AB and partner Eisai held several oral presentations at the 14th Clinical Trials on Alzheimer’s Disease conference, November 9-12, 2021, revealing new data on lecanemab, an investigational anti-amyloid beta protofibril antibody.

Hansa Biopharma AB, “Hansa”, announces its decision to initiate a pivotal Phase 3 clinical study of imlifidase to treat anti-GBM disease, following a successful pre-IND meeting with the U.S. Food and Drug Administration.

Oncopeptides AB, a biotech company focused on research and development of therapies for difficult-to-treat hematological diseases, announces that the Board of Directors has appointed Jakob Lindberg as Chief Executive Officer, CEO of Oncopeptides.

Orthogon Therapeutics LLC, a drug development company focused on designing innovative antivirals and anti-infective therapeutics, announced that it has appointed Dr. Marie Lindner as an independent director to its board of directors.

BiondVax Pharmaceuticals Ltd. announced that Chief Executive Officer Amir Reichman will present a company overview at the H.C. Wainwright 7th Annual Israel Virtual Conference Nov. 15, 2021 at 10:30 am ET.

RadNet, Inc., a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, announced that Mark Stolper, Executive Vice President and Chief Financial Officer, will be presenting virtually during a fireside chat at the Jefferies 2021 London Healthcare Conference being held November 16-19, 2021.

IDEAYA Biosciences, Inc., a synthetic lethality focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, provided a business update and announced financial results for the third quarter ended September 30, 2021.